(CNN Español) – The vacancies that elaborate China against the coronavirus were presented as an option for various Latin American countries. Brazil, Mexico, Chile and Peru are some of the countries that have proven the vacancies of these countries.
The last time the doctor Elmer Huerta examined was the las vacunas de los laboratorios Sinopharm, CanSino and Sinovac.
You can listen to this episode on Apple Podcasts, Spotify or your favorite podcast platform, or learn the transcription and continuation.
Hello, soja el Dr. Elmer Huerta and this is his diary dose of information about the new coronavirus. Information that we hope will help us to take care of our health and that of our families.
The vacancies against the covid-19 are available
The vacancies of the mayor reconciliation general son the of Modern and of Pfizer, developed by scientific and German scientists, respectively.
Other vacancy boys gewilde son las from the University of Oxford, developed in alliance with the laboratory AstraZeneca, and the Johnson & Johnson. It is a recognition that is likely to have the prestige of the University of Oxford and the multiple products of the Johnson & Johnson pharmaceutical diary use.
But in the last weeks he has been listening to a lot of Chinese vacancies. They are positioned in Latin America as important alternatives to previously mentioned vacancies.
We have a brief review of the vacancies in China.
China vacancies against coronavirus
His three main Chinese laboratories he developed vacancies against covid-19: Sinopharm, CanSino and Sinovac.
We will repeat one by one.
Sinopharm Vacuna
The Sinopharm laboratory has two vacancies, the numbers -for reasons not clear- have been unveiled as part of a coronavirus obtained from a patient in Beijing and another patient in Wuhan.
Both types of viruses are cultivated and they are obtained from vacancies that develop following the traditional method of inactivating with chemical substances.
Once disabled, viruses spread their ability to cause infection, while maintaining their ability to withstand the formation of neutralizing antispasmodics by the defense system.
The results published in The Lancet, in the year 2021, show that the vacancies developed by Sinopharm in Beijing, which has been approved in China, are sure and capable of estimating the production of neutralizing anticorrosives.
With respect to the vaccine efficacy required for dosing, it was estimated at 79.34%, as of December 31, it was approved for use by the Chinese regulatory entity.
Currently, Sinopharm’s vacancies are being tested in Phase 3 mayoralty in 10 countries of Latin America and the Middle East, and a large sale for its use in median countries in large quantities is what is required for conciliation and alimony transport.
Recently, the Governor of Peru announced the purchase of 38 million doses of the Sinopharm vaccine.
CanSino Vacuna
The CanSino laboratory, in association with the Institute of Biology of the Academy of Military Medical Sciences of China, developed a vaccine of a dose based on a vector, called Ad5.
Its Phase 1 studies will be published in May in The Lancet and its Phase 2 studies, published in July, will demonstrate that the vaccine will produce a strong immune system, and a precedent-setting movement, approved by China in June. to consider a “special drug”.
CanSino launched in August its Phase 3 studies in various countries, including Pakistan, Russia, Mexico and Chile.
This March, to see if the results of the vaccine’s efficiencies are not available, the President of Mexico Manuel Andrés López Obrador announced that – to approve – he will be vaccinated with this vaccine in February.
Vacuna de Sinovac
For its part, Sinovac’s laboratory, a private Chinese company, developed a vaccine called CoronaVac, although Sinopharm is based on an inactivated virus.
Phase 1-2 studies published by The Lancet, in November 2020, demonstrated to 743 volunteers who had a comparatively modest neutralizing anti-body production, while presenting serious adverse effects.
CoronaVac’s efficiency has been a period of inconvenience, it was announced on the 12th of January that, in a Phase 3 study developed in Brazil, the vacancies increased by 50.38% of commodity efficiencies, which could prevent 78% of cases hef y el 100% de casos moderados y severos.
In summary, Chinese vacancies, with the exception of Sinovac, have high levels of efficiencies, and all demonstrated high levels of secondary effects.
Due to the widespread use of communal refrigerators, Chinese vehicles have a large use of median and inferior parts of the country. Lamentably, these vacancies will be one of the most expensive in the market.
Do you have any questions about coronavirus?
We will post your questions on Twitter, we intend to respond to our upcoming episodes. You can find in @DrHuerta. You have not responded yet.
If you think this podcast is useful, you can help others find, rate and revise it in your favorite podcast application. Volveremos mañana, as well as making sure to subscribe to get the ultimate episode on your account.
For more information, please send a CNNEspanol.com. Thank you for your attention.